Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma?

Earn CME for related activities: www.naccme.com/oln
In this webcast from the 'Treatment for Marginal Zone Lymphoma: Should it be Different from FL?' symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Thomas M. Habermann discusses whether treatment of marginal zone lymphoma (MZL) should be different than that of follicular lymphoma.
© 2019 Imedex, an HMP Company

[@tomaffatigato1498]

Sad that so few studies are done with MZL

[@hoomanparsi]

Usually these videos are good but this wasn’t very informative